Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Wedbush Maintains Outperform on Apple, Raises Price Target to $220

Wedbush analyst Daniel Ives maintains Apple (NASDAQ:AAPL) with a Outperform and raises the price target from $200 to $220.

byBenzinga Newsdesk

August 17, 2022

1 minute read

Wedbush analyst Daniel Ives maintains Apple (NASDAQ:AAPL) with a Outperform and raises the price target from $200 to $220.

Bit Digital, Inc. Announces Update Related to Hosting Partner’s Operations

By Michael Horton

October 7, 5:01 PM

NEW YORK, Oct. 7, 2022 /PRNewswire/ -- Bit Digital, Inc. (NASDAQ:BTBT) ("Bit Digital" or the "Company"), a digital asset mining company headquartered in New York, announced updates related to its hosting partner's

BTBT

FTC Commission Chair Tells White House She Is Concerned About Recent Consolidation In Oil And Gas Industry, Stemming From FTC Merger Review Practices

By Benzinga Newsdesk

August 30, 9:46 AM

-Reuters

SPY

Analyst Ratings

8 Analysts Have This to Say About Carrier Global

By Benzinga Insights

October 13, 3:22 PM

Analysts have provided the following ratings for Carrier Global (NYSE:CARR) within the last quarter:

CARR

Soligenix Says Thermostable Vaccine Technology Platform To Be Presented At 6th International Conference On Vaccines Research And Development

By Benzinga Newsdesk

November 1, 7:31 AM

Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical

SNGX

Wedbush Maintains Outperform on Apple, Raises Price Target to $220

Related Posts

Bit Digital, Inc. Announces Update Related to Hosting Partner’s Operations

FTC Commission Chair Tells White House She Is Concerned About Recent Consolidation In Oil And Gas Industry, Stemming From FTC Merger Review Practices

8 Analysts Have This to Say About Carrier Global

Soligenix Says Thermostable Vaccine Technology Platform To Be Presented At 6th International Conference On Vaccines Research And Development